Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Specialty Solutions Spotlight: Hospital Discharge Planning in Workers’ Comp
Prior to leaving the hospital, injured employees need a well-organized plan to ensure a successful transition home. This plan should include arrangements for essential services like durable medical equipment (DME), home health care, transportation and diagnostic services, especially in cases involving complex injuries.
Ask The Pharmacist: Marijuana and Controlled Substance Classifications
Recently, the U.S. Department of Justice (DOJ) proposed rescheduling marijuana from a Schedule I to a Schedule III controlled substance. This change follows a review requested by President Biden in 2022 and supported by medical and legal evaluations from the Department of Health and Human Services (HHS) and the Justice Department’s Office of Legal Counsel (OLC). The rulemaking process will include public notice, comments and an administrative hearing before any final decision is made.
The Intelligence Report
Enlyte has partnered with Snowflake to bring next generation data capabilities. A data platform built to store and centralize access to data quickly and easily is the key to developing advanced analytics.
Navigating the Complex Landscape of Utilization Review in Workers' Compensation
Learn about the crucial role of Utilization Review (UR) in the workers' compensation system, the importance of regulatory compliance, and the impact of state-by-state jurisdictional nuances.
Enlyte’s Q2 Medical Price Index Shows Increases In Comp and Auto Injury Services
Medical costs nationally have risen 11% in workers’ comp and 5% in auto first-party over the past four years, despite a slowing of growth over the past two years, according to new data released by Enlyte today.
Return-to-work strategies for LGBTQ+ Injured Employees
Celebrate Pride Month by reflecting on the progress of LGBTQ+ equality and addressing health care disparities. Join Genex case manager Chikita Mann, MSN, RN, CCM, as she explores this crucial topic.